Suppr超能文献

蛋白激酶C(PKC)同工酶在药物敏感和多药耐药KB细胞中的表达、亚细胞分布及对佛波酯的反应:PKC-α调节改变的证据

Expression, subcellular distribution and response to phorbol esters of protein kinase C (PKC) isozymes in drug-sensitive and multidrug-resistant KB cells evidence for altered regulation of PKC-alpha.

作者信息

Cloud-Heflin B A, McMasters R A, Osborn M T, Chambers T C

机构信息

Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock 72205-7199, USA.

出版信息

Eur J Biochem. 1996 Aug 1;239(3):796-804. doi: 10.1111/j.1432-1033.1996.0796u.x.

Abstract

Protein kinase C (PKC) comprises a family of related phospholipid-dependent serine/threonine protein kinases. PKC has been implicated in the induction and maintenance of the multidrug-resistance (MDR) phenotype but the role of different isozymes is not well understood. We compared the expression and subcellular distribution, and membrane association and down-regulation induced by phorbol esters, of individual PKC isozymes in drug-sensitive KB-3 and multidrug-resistant KB-V1 human carcinoma cell lines. Immunoblotting with isozyme-specific antibodies indicated the presence of PKC alpha (cytosol only). PKC beta (membrane only). PKC epsilon (mainly membrane associated) and PKC zeta (both fractions). PKC delta and PKC gamma were not detected. The expression levels of PKC beta. PKC epsilon and PKC zeta were unchanged in KB-V1 cells; PKC alpha was modestly increased ( approximately 65%) in the resistant cells as further determined by enzyme assay. The cytosolic nature and increased expression of PKC alpha were confirmed by immunofluorescent localization studies. Revertant cells, obtained by culturing KB-V1 cells in a drug-free medium, regained drug sensitivity with a loss of P-glycoprotein and a concomitant decrease in expression of PKC alpha, KB-V1 cells were found to differ markedly from KB-3 cells with respect to the translocation and down-regulation specifically of PKC alpha upon exposure to 12-O-tetradecanoyl-1-phorbol-13-acetate (TPA). Treatment with 30 nM TPA for 24 h completely depleted KB-3 cells of PKC alpha whereas 1 microM TPA was required to deplete KB-V1 cells of PKC alpha. Similar results were obtained when phorbol-12, 13-dibutyrate was used instead of TPA. Defective TPA-mediated down-regulation of PKC alpha was also observed in another PKC alpha-overexpressing MDR cell line. KB-A1. Importantly, cellular uptake of radiolabeled phorbol ester was similar for both drug-sensitive and MDR cells. Sensitive and resistant cells exhibited similar expression levels of RACK1, a PKC-binding protein important in activation-induced translocation. These findings further highlight the importance of PKC alpha in the MDR phenotype, and suggest that this isozyme may be expressed in a modified form or be subject to an altered regulation in MDR cells.

摘要

蛋白激酶C(PKC)是一族相关的磷脂依赖性丝氨酸/苏氨酸蛋白激酶。PKC与多药耐药(MDR)表型的诱导和维持有关,但不同同工酶的作用尚未完全明了。我们比较了药物敏感的KB-3和多药耐药的KB-V1人癌细胞系中各PKC同工酶的表达、亚细胞分布、膜结合情况以及佛波酯诱导的下调情况。用同工酶特异性抗体进行免疫印迹分析表明,存在PKCα(仅存在于胞质溶胶中)、PKCβ(仅存在于细胞膜上)、PKCε(主要与细胞膜结合)和PKCζ(在两种组分中均有)。未检测到PKCδ和PKCγ。KB-V1细胞中PKCβ、PKCε和PKCζ的表达水平未发生变化;通过酶活性测定进一步确定,耐药细胞中PKCα适度增加(约65%)。免疫荧光定位研究证实了PKCα的胞质性质及其表达增加。通过在无药培养基中培养KB-V1细胞获得的回复细胞恢复了药物敏感性,同时P-糖蛋白丢失,PKCα的表达也随之降低。发现KB-V1细胞在暴露于12-O-十四烷酰佛波醇-13-乙酸酯(TPA)后,PKCα的易位和下调情况与KB-3细胞明显不同。用30 nM TPA处理24小时可使KB-3细胞中的PKCα完全耗尽,而需要1 μM TPA才能使KB-V1细胞中的PKCα耗尽。当使用佛波醇-12,13-二丁酸酯代替TPA时,也得到了类似的结果。在另一个PKCα过表达的MDR细胞系KB-A1中也观察到TPA介导的PKCα下调存在缺陷。重要的是,放射性标记佛波酯在药物敏感细胞和MDR细胞中的细胞摄取情况相似。敏感细胞和耐药细胞中RACK1(一种在激活诱导易位中起重要作用的PKC结合蛋白)的表达水平相似。这些发现进一步突出了PKCα在MDR表型中的重要性,并表明该同工酶可能以修饰形式表达或在MDR细胞中受到改变的调节。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验